Peroxisomal Biogenesis Factor 19 (PEX19) Peptide
PEX19
适用: 哺乳动物
宿主: 合成
BP, WB, IHC
-
- 抗原 See all PEX19 products
- PEX19 (Peroxisomal Biogenesis Factor 19 (PEX19))
- 蛋白类型
- Synthetic
- 宿主
- 哺乳动物
-
资源
- 合成
- 应用范围
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- 序列
- AETPTDSETT QKARFEMVLD LMQQLQDLGH PPKELAGEMP PGLNFDLDAL
- 产品特性
-
A synthetic peptide for use as a blocking control in assays to test for specificity of PEX19 antibody,
Alternative Names: PEX19 control peptide, PEX19 antibody Blocking Peptide, Anti-PEX19 Blocking Peptide, peroxisomal biogenesis factor 19 Blocking Peptide, D1S2223E Blocking Peptide, FLJ55296 Blocking Peptide, HK33 Blocking Peptide, PMP1 Blocking Peptide, PMPI Blocking Peptide, PXF Blocking Peptide, PXMP1 Blocking Peptide, PEX19, PEX-19, PEX 19, PEX-19 Blocking Peptide, PEX 19 Blocking Peptide
-
-
- 应用备注
- Optimal conditions should be determined by the investigator
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- 缓冲液
- PBS
- 注意事项
- Avoid repeated freeze/thaw cycles.
- 储存条件
- -20 °C
- 储存方法
- Store at -20 °C long term.
-
- 抗原
- PEX19 (Peroxisomal Biogenesis Factor 19 (PEX19))
- 别名
- BEST:GH03076 Peptide, CG5325 Peptide, DmelPex19 Peptide, Dmel\\CG5325 Peptide, D1S2223E Peptide, HK33 Peptide, PBD12A Peptide, PMP1 Peptide, PMPI Peptide, PXF Peptide, PXMP1 Peptide, Pxf Peptide, PxF Peptide, Peroxin-19 Peptide, Peroxin 19 Peptide, Peroxisomal farnesylated protein Peptide, peroxisomal biogenesis factor 19 Peptide, Pex19 Peptide, Bm1_19905 Peptide, PEX19 Peptide
- 背景
- This gene is necessary for early peroxisomal biogenesis. It acts both as a cytosolic chaperone and as an import receptor for peroxisomal membrane proteins (PMPs). Peroxins (PEXs) are proteins that are essential for the assembly of functional peroxisomes. The peroxisome biogenesis disorders (PBDs) are a group of genetically heterogeneous autosomal recessive, lethal diseases characterized by multiple defects in peroxisome function. These disorders have at least 14 complementation groups, with more than one phenotype being observed for some complementation groups. Although the clinical features of PBD patients vary, cells from all PBD patients exhibit a defect in the import of one or more classes of peroxisomal matrix proteins into the organelle. Defects in this gene are a cause of Zellweger syndrome (ZWS), as well as peroxisome biogenesis disorder complementation group 14 (PBD-CG14), which is also known as PBD-CGJ. Alternative splicing results in multiple transcript variants.
- 分子量
- 33 kDa
-
You are here:
